EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC. (12th June 2019) - Radford, J.; Connors, J.M.; Younes, A.; Gallamini, A.; Ansell, S.M.; Kim, W.S.; Cheong, J.; Flinn, I.; Kalakonda, N.; Kaminski, M.; Pettengell, R.; Onsum, M.; et al.